Alto Neuroscience Inc.

ANRONYSE • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
27.04 USD
↗ 1.74 (6.88%)AT CLOSE (11:59 AM EDT)
26.93
↘ 0.11 (0.41%)
POST MARKET (AS OF 07:27 PM EDT)
Post Market
AS OF 07:27 PM EDT
26.93
↘ 0.11 (0.41%)
🔴Market: CLOSED

Alto Neuroscience Inc. (ANRO) trades at $27.04 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ANRO at a fair price relative to peers.

Technical & fundamental data as of Jun 26, 2026.

Open?$25.03
High?$27.11
Low?$24.89
Prev. Close?$25.30
Volume?4.4M
Avg. Volume?491.1K
VWAP?$26.14
Rel. Volume?8.99x
Bid / Ask
Bid?$25.30 × 100
Ask?$26.93 × 100
Spread?$1.63
Midpoint?$26.12
Valuation & Ratios
Market Cap?948.9M
Shares Out?35.1M
Float?23.9M
Float %?75.0%
P/E Ratio?N/A
P/B Ratio?3.90
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
68
Market Cap
887.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.altoneuroscience.com
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
49
Piotroski F-Score?0/9Weak
Altman Z-Score?16.34Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.77%Elevated
Short Interest?1.6M
Days to Cover?4.3
Free Float23.9M
Avg Daily Volume373.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?20.52Strong
Quick Ratio?20.52Strong
Cash Ratio?20.11Strong
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
45
3.90FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-30.5%WEAK▾
ROA?
S&P
3
-26.9%WEAK▾
Cash Flow & Enterprise
FCF?$-62860000
Enterprise Value?$703.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist